Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Ghosh, Zhumur ^a   Wilson, Kitchener D ^a,b   Wu, Yi ^a   Hu, Shijun ^a   Quertermous, Thomas ^a   Wu, Joseph C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Stanford University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE CELL; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYONIC STEM CELL; FIBROBLAST; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; MICROARRAY ANALYSIS; PLURIPOTENT STEM CELL; UPREGULATION; ADIPOSE TISSUE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CLUSTER ANALYSIS; CYTOLOGY; DNA MICROARRAY; FETUS; GENETICS; METABOLISM; METHODOLOGY; NEWBORN; STEM CELL;

ADIPOSE TISSUE; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELLS, CULTURED; CLUSTER ANALYSIS; EMBRYONIC STEM CELLS; FETUS; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INFANT, NEWBORN; KERATINOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STEM CELLS;

EID: 77957325592     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008975     Document Type: Article

References (47)

1. Stojkovic M, Lako M, Strachan T, Murdoch A (2004) Derivation, growth and applications of human embryonic stem cells. Reproduction 128: 259-267.
2. Nishikawa S-i, Goldstein R, Nierras C (2008) The promise of human induced pluripotent stem cells for research and therapy. Nature Reviews Molecular Cell Biology 9: 725-729.
3. Sipp D (2009) Gold standards in the diamond age: the commodification of pluripotency. Cell Stem Cell 5: 360-363.
4. Swijnenburg R-J, Schrepfer S, Cao F, Pearl J, Xie X, et al. (2008) In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation. Stem Cells and Development 17: 1023-1029.
5. Swijnenburg R-J, Schrepfer S, Govaert J, Cao F, Ransohoff K, et al. (2008) Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proceedings of the National Academy of Sciences of the United States of America 105: 12991-12996.
6. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
7. Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, et al. (2008) Generation of human induced pluripotent stem cells from dermal fibroblasts. Proceedings of the National Academy of Sciences of the United States of America 105: 2883-2888.
8. Park I-H, Lerou P, Zhao R, Huo H, Daley G (2008) Generation of human-induced pluripotent stem cells. Nature Protocols 3: 1180-1186.
9. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
10. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
11. Aasen T, Raya A, Barrero M, Garreta E, Consiglio A, et al. (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nature Biotechnology 26: 1276-1284.
12. Kim D, Kim C-H, Moon J-I, Chung Y-G, Chang M-Y, et al. (2009) Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4: 472-476.
13. Loh YH, Agarwal S, Park IH, Urbach A, Huo H, et al. (2009) Generation of induced pluripotent stem cells from human blood. Blood 113: 5476-5479.
14. Marchetto MCN, Yeo G, Kainohana O, Marsala M, Gage F, et al. (2009) Transcriptional signature and memory retention of human-induced pluripotent stem cells. PloS ONE 4: e7076.
15. Sun N, Panetta NJ, Gupta DM, Wilson KD, Lee A, et al. (2009) Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. PNAS 106: 15720-15725.
16. Utikal J, Maherali N, Kulalert W, Hochedlinger K (2009) Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J Cell Sci 122: 3502-3510.
17. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, et al. (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324: 797-801.
18. Sun N LM, Wu J (2010) Human iPS cell-based therapy: considerations before clinical applications. Cell Cycle (in press).
19. Chin M, Mason M, Xie W, Volinia S, Singer M, et al. (2009) Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5: 111-123.
20. Miura K, Okada Y, Aoi T, Okada A, Takahashi K, et al. (2009) Variation in the safety of induced pluripotent stem cell lines. Nature Biotechnology 27: 743-745.
21. Li J-Y, Christophersen N, Hall V, Soulet D, Brundin P (2008) Critical issues of clinical human embryonic stem cell therapy for brain repair. Trends in Neurosciences 31: 146-153.
22. Yamanaka S (2009) A fresh look at iPS cells. Cell 137: 13-17.
23. Maherali N, Hochedlinger K (2008) Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3: 595-605.
24. Barrett T, Troup D, Wilhite S, Ledoux P, Rudnev D, et al. (2007) NCBI GEO: mining tens of millions of expression profiles-database and tools update. Nucleic Acids Research 35: D760-765.
25. Gibbons F, Roth F (2002) Judging the quality of gene expression-based clustering methods using gene annotation. Genome Research 12: 1574-1581.
26. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proceedings of the National Academy of Sciences of the United States of America 95: 14863-14868.
27. Calvano S, Xiao W, Richards D, Felciano R, Baker H, et al. (2005) A network-based analysis of systemic inflammation in humans. Nature 437: 1032-1037.
28. Gosiewska A, Yi CF, Brown LJ, Cullen B, Silcock D, et al. (2001) Differential expression and regulation of extracellular matrix-associated genes in fetal and neonatal fibroblasts. Wound Repair and Regeneration 9: 213-222.
29. Zuk PA ZM, Ashjian P, De Ugarte DA, Huang JI, et al. (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295.
30. Bunnell B, Flaat M, Gagliardi C, Patel B, Ripoll C (2008) Adipose-derived stem cells: isolation, expansion and differentiation. Methods 45: 115-120.
31. Fuchs E (2007) Scratching the surface of skin development. Nature 445: 834-842.
32. Rinn J, Bondre C, Gladstone H, Brown P, Chang H (2006) Anatomic demarcation by positional variation in fibroblast gene expression programs. PLoS Genetics 2: e119.
33. Dahlman I, Linder K, Arvidsson Nordstrom E, Andersson I, Liden J, et al. (2005) Changes in adipose tissue gene expression with energy-restricted diets in obese women. Am J Clin Nutr 81: 1275-1285.
34. Jernas M, Palming J, Sjoholm K, Jennische E, Svensson PA, et al. (2006) Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J 20: 1540-1542.
35. Sjöholm K PJ, Olofsson LE, Gummesson A, Svensson PA (2005) A Microarray Search for Genes Predominantly Expressed in Human Omental Adipocytes: Adipose Tissue as a Major Production Site of Serum Amyloid A. J Clin Endocrinol Metab 90: 2233-2239.
36. Urs S, Smith C, Campbell B, Saxton AM, Taylor J, et al. (2004) Gene expression profiling in human preadipocytes and adipocytes by microarray analysis. J Nutr 134: 762-770.
37. Gazel A, Ramphal P, Rosdy M, De Wever B, Tornier C, et al. (2003) Transcriptional profiling of epidermal keratinocytes: comparison of genes expressed in skin, cultured keratinocytes, and reconstituted epidermis, using large DNA microarrays. The Journal of Investigative Dermatology 121: 1459-1468.
38. Yih L-H, Peck K, Lee T-C (2002) Changes in gene expression profiles of human fibroblasts in response to sodium arsenite treatment. Carcinogenesis 23: 867-876.
39. Chang H, Chi J-T, Dudoit S, Bondre C, van de Rijn M, et al. (2002) Diversity, topographic differentiation, and positional memory in human fibroblasts. Proceedings of the National Academy of Sciences of the United States of America 99: 12877-12882.
40. Nakatake Y, Fukui N, Iwamatsu Y, Masui S, Takahashi K, et al. (2006) Klf4 cooperates with Oct3/4 and Sox2 to activate the Lefty1 core promoter in embryonic stem cells. Mol Cell Biol 26: 7772-7782.
41. Fong H, Hohenstein KA, Donovan PJ (2008) Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells. Stem Cells 26: 1931-1938.
42. Miura T, Mattson MP, Rao MS (2004) Cellular lifespan and senescence signaling in embryonic stem cells. Aging Cell 3: 333-343.
43. Mongan NP, Martin KM, Gudas LJ (2006) The putative human stem cell marker, Rex-1 (Zfp42): structural classification and expression in normal human epithelial and carcinoma cell cultures. Mol Carcinog 45: 887-900.
44. Graf T, Stadtfeld M (2008) Heterogeneity of embryonic and adult stem cells. Cell Stem Cell 3: 480-483.
45. Huang S (2009) Reprogramming cell fates: reconciling rarity with robustness. BioEssays 31: 546-560.
46. Chang H, Oh P, Ingber D, Huang S (2006) Multistable and multistep dynamics in neutrophil differentiation. BMC Cell Biology 7: 11-11.
47. Waddington CH (1957) The Strategy of the Genes; a Discussion of Some Aspects of Theoretical Biology (London: Allen & Unwin).